Moleculent
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- $46M
Investors
- 3
About Moleculent
Based in Solna, Sweden and founded in 2021, Moleculent AB is a biotechnology research platform that engages in cell and oncology research. The company was co-founded by Olle Ericsson, and Fredrik Ross. The company has developed technology to investigate high-plex interactions between cells, exposing the complex molecular mechanisms and signaling cascades behind a range of medical disorders. Moleculent's primary product is a platform that enables the direct measurement of cell-cell interactions inside their tissue milieu. This technique makes it possible to do at-scale functional proteomics by illuminating both the functional characteristics of healthy cells and the anomalies present in diseased cells. The company’s revenue is generated by providing its functional profiling platform and related biological research solutions to biotechnology, pharmaceutical, and academic research organizations. Customers utilize its technology to study cell-cell interactions, tissue biology, and disease mechanisms.
Who invested in Moleculent
3 investors across 2 rounds
See all investors in Moleculent
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Moleculent
Who invested in Moleculent?
Moleculent has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Moleculent raised?
Moleculent has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Moleculent last raise money?
Moleculent's most recent round on record is a Series A, in Apr 2026.
What does Moleculent do?
Based in Solna, Sweden and founded in 2021, Moleculent AB is a biotechnology research platform that engages in cell and oncology research.
Where is Moleculent headquartered?
Moleculent is headquartered in Solna, Sweden.
Which VCs invest in companies like Moleculent?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Moleculent's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Moleculent? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.